Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin vs. Atorvastatin/Ezetimibe in Patients With Hypo-response to Initial Dose Statin Therapy

NCT00965055 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT00965055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00965055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin vs. Atorvastatin/Ezetimibe in Patients With Hypo-response to Initial Dose Statin Therapy
Lead sponsor
University of California, San Diego
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2009
Completion date
September 30, 2012
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, high cholesterol